• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症激酶Mirk/dyrk1B的正常功能是减少活性氧。

The normal function of the cancer kinase Mirk/dyrk1B is to reduce reactive oxygen species.

作者信息

Deng Xiaobing, Mercer Stephen E, Sun Chi-Yu, Friedman Eileen

机构信息

Pathology Department, Upstate Medical University, Syracuse, New York.

出版信息

Genes Cancer. 2014 Apr;5(1-2):22-30. doi: 10.18632/genesandcancer.1.

DOI:10.18632/genesandcancer.1
PMID:24955215
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4063251/
Abstract

Mirk kinase is a gene upregulated and sometimes amplified in pancreatic cancers and in ovarian cancers, but expressed at very low levels in most normal diploid cells except for skeletal muscle. The muscle cell function of Mirk kinase selected for by cancer cells is unknown. It is now shown that Mirk protein is expressed at low levels and is largely nuclear in cycling skeletal muscle C2C12 myoblasts, but is translocated to the cytoplasm and upregulated when myoblasts initiate differentiation, as shown by immunofluorescence staining and by cell fractionation. Either Mirk depletion or Mirk kinase inhibition increased ROS levels in cycling C2C12 myoblasts. However, Mirk protein is localized in the cytoplasm of mature muscle fibers, specifically in the fast twitch fibers of human skeletal muscle where toxic ROS levels are generated by muscle contraction. C2C12 myoblasts at high density in differentiation media fuse to form differentiated postmitotic myotubes that can contract. A Mirk kinase inhibitor induced a dose-dependent increase in ROS in this model for fast twitch fibers of human skeletal muscle. Efficient Mirk depletion in SU86.86 pancreatic cancer cells by an inducible shRNA decreased expression of eight antioxidant genes. Thus both cancer cells and differentiated myotubes utilize Mirk kinase to relieve oxidative stress.

摘要

Mirk激酶是一种在胰腺癌和卵巢癌中上调且有时会扩增的基因,但在除骨骼肌外的大多数正常二倍体细胞中表达水平极低。癌细胞选择的Mirk激酶的肌肉细胞功能尚不清楚。现在研究表明,Mirk蛋白在增殖的骨骼肌C2C12成肌细胞中表达水平较低且主要位于细胞核中,但通过免疫荧光染色和细胞分级分离显示,当成肌细胞开始分化时,它会转移到细胞质并上调表达。Mirk缺失或Mirk激酶抑制均会增加增殖的C2C12成肌细胞中的活性氧水平。然而,Mirk蛋白定位于成熟肌纤维的细胞质中,特别是在人类骨骼肌的快肌纤维中,在那里肌肉收缩会产生活性氧毒性水平。处于分化培养基中的高密度C2C12成肌细胞融合形成可收缩的分化后有丝分裂后肌管。在该人类骨骼肌快肌纤维模型中,Mirk激酶抑制剂诱导活性氧呈剂量依赖性增加。通过可诱导的短发夹RNA在SU86.86胰腺癌细胞中有效缺失Mirk会降低八个抗氧化基因的表达。因此,癌细胞和分化的肌管均利用Mirk激酶来减轻氧化应激。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d75/4063251/b2a2ab18c079/ganc-05-022-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d75/4063251/e3ecb534070f/ganc-05-022-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d75/4063251/c3a4f8842343/ganc-05-022-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d75/4063251/2f1134496100/ganc-05-022-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d75/4063251/9469589c7c57/ganc-05-022-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d75/4063251/b2a2ab18c079/ganc-05-022-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d75/4063251/e3ecb534070f/ganc-05-022-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d75/4063251/c3a4f8842343/ganc-05-022-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d75/4063251/2f1134496100/ganc-05-022-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d75/4063251/9469589c7c57/ganc-05-022-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9d75/4063251/b2a2ab18c079/ganc-05-022-g005.jpg

相似文献

1
The normal function of the cancer kinase Mirk/dyrk1B is to reduce reactive oxygen species.癌症激酶Mirk/dyrk1B的正常功能是减少活性氧。
Genes Cancer. 2014 Apr;5(1-2):22-30. doi: 10.18632/genesandcancer.1.
2
Mirk/dyrk1B is a Rho-induced kinase active in skeletal muscle differentiation.Mirk/dyrk1B是一种在骨骼肌分化过程中具有活性的Rho诱导激酶。
J Biol Chem. 2003 Oct 17;278(42):41347-54. doi: 10.1074/jbc.M306780200. Epub 2003 Aug 5.
3
Mirk/Dyrk1B mediates survival during the differentiation of C2C12 myoblasts.Mirk/Dyrk1B在C2C12成肌细胞分化过程中介导细胞存活。
J Biol Chem. 2005 Jul 8;280(27):25788-801. doi: 10.1074/jbc.M413594200. Epub 2005 Apr 25.
4
Ovarian cancer cells, not normal cells, are damaged by Mirk/Dyrk1B kinase inhibition.Mirk/Dyrk1B 激酶抑制可损伤卵巢癌细胞而非正常细胞。
Int J Cancer. 2013 May 15;132(10):2258-69. doi: 10.1002/ijc.27917. Epub 2012 Nov 21.
5
Mirk/Dyrk1B maintains the viability of quiescent pancreatic cancer cells by reducing levels of reactive oxygen species.Mirk/Dyrk1B通过降低活性氧水平来维持静止胰腺癌细胞的活力。
Cancer Res. 2009 Apr 15;69(8):3317-24. doi: 10.1158/0008-5472.CAN-08-2903. Epub 2009 Apr 7.
6
Mirk kinase inhibition targets ovarian cancer ascites.Mirk激酶抑制作用靶向卵巢癌腹水。
Genes Cancer. 2014 May;5(5-6):201-11. doi: 10.18632/genesandcancer.19.
7
The cyclin-dependent kinase inhibitor p27Kip1 is stabilized in G(0) by Mirk/dyrk1B kinase.细胞周期蛋白依赖性激酶抑制剂p27Kip1在G(0)期通过Mirk/dyrk1B激酶实现稳定。
J Biol Chem. 2004 May 21;279(21):22498-504. doi: 10.1074/jbc.M400479200. Epub 2004 Mar 9.
8
Depleting Mirk Kinase Increases Cisplatin Toxicity in Ovarian Cancer Cells.耗尽Mirk激酶会增加卵巢癌细胞对顺铂的毒性。
Genes Cancer. 2010 Aug 1;1(8):803-811. doi: 10.1177/1947601910377644.
9
Mirk/dyrk1B decreases the nuclear accumulation of class II histone deacetylases during skeletal muscle differentiation.Mirk/dyrk1B在骨骼肌分化过程中减少II类组蛋白去乙酰化酶的核内积累。
J Biol Chem. 2005 Feb 11;280(6):4894-905. doi: 10.1074/jbc.M411894200. Epub 2004 Nov 16.
10
Mirk kinase inhibition blocks the in vivo growth of pancreatic cancer cells.Mirk激酶抑制作用可阻断胰腺癌细胞的体内生长。
Genes Cancer. 2014 Sep;5(9-10):337-47. doi: 10.18632/genesandcancer.29.

引用本文的文献

1
A safe haven for cancer cells: tumor plus stroma control by DYRK1B.癌细胞的避风港:DYRK1B对肿瘤与基质的调控
Oncogene. 2025 Feb;44(6):341-347. doi: 10.1038/s41388-025-03275-6. Epub 2025 Jan 25.
2
Increased Myocardial MAO-A, Atrogin-1, and IL-1β Expression in Transgenic Mice with Pancreatic Carcinoma-Benefit of MAO-A Inhibition for Cardiac Cachexia.胰腺癌转基因小鼠中心肌单胺氧化酶A、肌肉萎缩F-box蛋白1及白细胞介素-1β表达增加——单胺氧化酶A抑制对心脏恶病质的益处
Biomedicines. 2024 Sep 3;12(9):2009. doi: 10.3390/biomedicines12092009.
3
Effects of Monoamino-Oxidase-A (MAO-A) Inhibition on Skeletal Muscle Inflammation and Wasting through Pancreatic Ductal Adenocarcinoma in Triple Transgenic Mice.

本文引用的文献

1
Modulating mitochondrial intracellular location as a redox signal.作为一种氧化还原信号调节线粒体的细胞内定位。
Sci Signal. 2012 Sep 18;5(242):pe39. doi: 10.1126/scisignal.2003386.
2
Doxorubicin acts via mitochondrial ROS to stimulate catabolism in C2C12 myotubes.多柔比星通过线粒体 ROS 刺激 C2C12 肌管中的分解代谢。
Am J Physiol Cell Physiol. 2012 Jan 1;302(1):C195-202. doi: 10.1152/ajpcell.00217.2011. Epub 2011 Sep 21.
3
Peroxiredoxin-2 upregulated by NF-κB attenuates oxidative stress during the differentiation of muscle-derived C2C12 cells.
单胺氧化酶A(MAO-A)抑制对三转基因小鼠胰腺导管腺癌引起的骨骼肌炎症和消瘦的影响。
Biomedicines. 2023 Mar 15;11(3):912. doi: 10.3390/biomedicines11030912.
4
Quiescent Cancer Cells-A Potential Therapeutic Target to Overcome Tumor Resistance and Relapse.静止期癌细胞——克服肿瘤耐药和复发的潜在治疗靶点。
Int J Mol Sci. 2023 Feb 13;24(4):3762. doi: 10.3390/ijms24043762.
5
Novel Efficient Multistage Lead Optimization Pipeline Experimentally Validated for DYRK1B Selective Inhibitors.新型高效多阶段先导化合物优化管道经实验验证可用于 DYRK1B 选择性抑制剂。
J Med Chem. 2022 Oct 27;65(20):13784-13792. doi: 10.1021/acs.jmedchem.2c00988. Epub 2022 Oct 14.
6
CIRBP Knockdown Attenuates Tumourigenesis and Improves the Chemosensitivity of Pancreatic Cancer via the Downregulation of DYRK1B.通过下调DYRK1B,CIRBP基因敲低可减弱胰腺癌的肿瘤发生并提高其化学敏感性。
Front Cell Dev Biol. 2021 Aug 20;9:667551. doi: 10.3389/fcell.2021.667551. eCollection 2021.
7
Mitochondrial Stress-Mediated Targeting of Quiescent Cancer Stem Cells in Oral Squamous Cell Carcinoma.线粒体应激介导的口腔鳞状细胞癌中静止癌症干细胞的靶向作用
Cancer Manag Res. 2020 Jun 15;12:4519-4530. doi: 10.2147/CMAR.S252292. eCollection 2020.
8
Competitive oxidation and ubiquitylation on the evolutionarily conserved cysteine confer tissue-specific stabilization of Insig-2.竞争氧化和泛素化作用在进化上保守的半胱氨酸上赋予 Insig-2 的组织特异性稳定。
Nat Commun. 2020 Jan 17;11(1):379. doi: 10.1038/s41467-019-14231-w.
9
How to design potent and selective DYRK1B inhibitors? Molecular modeling study.如何设计高效且具选择性的双重特异性酪氨酸磷酸酶样激酶1B(DYRK1B)抑制剂?分子模拟研究。
J Mol Model. 2019 Jan 23;25(2):41. doi: 10.1007/s00894-018-3921-3.
10
DYRK1A: the double-edged kinase as a protagonist in cell growth and tumorigenesis.DYRK1A:作为细胞生长和肿瘤发生主角的双刃剑激酶。
Mol Cell Oncol. 2015 Jan 30;2(1):e970048. doi: 10.4161/23723548.2014.970048. eCollection 2015 Jan-Mar.
NF-κB 上调过氧化物酶 2 减轻肌源性 C2C12 细胞分化过程中的氧化应激。
Antioxid Redox Signal. 2012 Feb 1;16(3):245-61. doi: 10.1089/ars.2011.3952. Epub 2011 Oct 21.
4
Changes in mitochondrial reactive oxygen species synthesis during differentiation of skeletal muscle cells.线粒体活性氧物种合成在骨骼肌细胞分化过程中的变化。
Mitochondrion. 2012 Jan;12(1):144-8. doi: 10.1016/j.mito.2011.06.015. Epub 2011 Jul 20.
5
DYRK1A protein kinase promotes quiescence and senescence through DREAM complex assembly.DYRK1A 蛋白激酶通过 DREAM 复合物组装促进静止和衰老。
Genes Dev. 2011 Apr 15;25(8):801-13. doi: 10.1101/gad.2034211.
6
Depleting Mirk Kinase Increases Cisplatin Toxicity in Ovarian Cancer Cells.耗尽Mirk激酶会增加卵巢癌细胞对顺铂的毒性。
Genes Cancer. 2010 Aug 1;1(8):803-811. doi: 10.1177/1947601910377644.
7
Mitochondrial redox potential during contraction in single intact muscle fibers.单个完整肌纤维收缩过程中线粒体氧化还原电势。
Muscle Nerve. 2010 Oct;42(4):522-9. doi: 10.1002/mus.21724.
8
The small chromatin-binding protein p8 coordinates the association of anti-proliferative and pro-myogenic proteins at the myogenin promoter.小染色质结合蛋白p8在肌细胞生成素启动子处协调抗增殖蛋白和促肌生成蛋白的结合。
J Cell Sci. 2009 Oct 1;122(Pt 19):3481-91. doi: 10.1242/jcs.048678. Epub 2009 Sep 1.
9
Role of free radicals and antioxidant signaling in skeletal muscle health and pathology.自由基和抗氧化信号在骨骼肌健康与病理中的作用。
Infect Disord Drug Targets. 2009 Aug;9(4):428-44. doi: 10.2174/187152609788922573.
10
Mirk/Dyrk1B maintains the viability of quiescent pancreatic cancer cells by reducing levels of reactive oxygen species.Mirk/Dyrk1B通过降低活性氧水平来维持静止胰腺癌细胞的活力。
Cancer Res. 2009 Apr 15;69(8):3317-24. doi: 10.1158/0008-5472.CAN-08-2903. Epub 2009 Apr 7.